News
-
-
PRESS RELEASE
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira receives Investigational Testing Authorizations from Health Canada for clinical trials on new applications of its Multiplo® TP/HIV rapid test, expanding testing options in Canada amid rising syphilis and HIV cases -
-
-
PRESS RELEASE
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Inc. receives Health Canada approval for Reveal® Rapid G4 HIV-1/2 Test for POC use. Achieves 99.64% sensitivity & 99.71% specificity. Test offers immediate results for HIV detection -
-
-
PRESS RELEASE
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
MedMira Inc. receives Health Canada authorization for clinical trials of Multiplo® Complete Syphilis Antibody Test. Innovative solution for active and past syphilis cases -
-